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EXPERIMENTAL METASTASES
Convenors-K. HELLMANN and R. CARTER
Workshop held at the laboratories of the Imperial Cancer Research Fund on 14 March 1974
The meeting opened with four orienta-
tional papers which were followed by labora-
tory demonstrations and discussions.
R. Carter described known and potential
tumour and host factors which could influence
the spread of tumours. First and foremost
among these were adhesiveness ofthe tumour
cells, release of cells with enhanced metastic
potential, vascularization both in its gross
andultrastructural characteristics andhaemo-
dynamics. The local andextracellular milieu
provided by different organs might have a
considerable influence and immune factors
might also possibly contribute to the localiza-
tion of disseminated tumour cells. He dis-
cussed some of these factors in terms of the
difference between a metastasizing and non-
metastasizing lymphoma in the guinea-pig.
F. Spreafico (Istituto di Ricerche Farma-
cologiche " Mario Negri ", Milan) described
models for selective metastasization. He
discussed firstly intracerebral transplantation
of cancer cells in mice using the sarcoma
S180 and the Ehrlich carcinoma. These
were introduced into the thalamic area ofthe
mouse brain. There was a direct relation-
ship between the number of cells injected and
the length of survival of the animals.
Secondly he discussed intratibial trans-
plantation (i.t.) to give lymph node secon-
daries in mice. When the Lewis lung
carcinoma was transplanted in this way the
highest incidence of lymph node involvement
was found to be in iliac nodes, but axillary
and other lymph nodes were not greatly
involved. The pattern of lymph node dis-
semination from i.t. 3LL primary was
very different from i.t. S180 and Ehrlich
carcinoma. Axillary lymph nodes are not
involved in 3LL spread but are very much
involved after i.t. injection of S180 or
Ehrlich carcinoma. The reason for this
difference in patterns of dissemination was
not known.
Portal vein inoculation with Lewis lung
carcinoma of 104 cells gave 12 out of 12
" takes " in the liver, but only 5 out of 12
animals had lung secondaries. Spreafico
also discussed direct implantation of cells
into the liver.
K. Hellmann described the Lewis lung
carcinoma system as an example of a tumour
which metastasizes via the blood stream.
He pointed out that its histological arrange-
ments closely resembled those of human
sarcomata and it might be a more useful
model for the behaviour of sarcomata than
for carcinomata. The introduction of this
system which metastasizes spontaneously,
to the same organ (the lungs) at the same
time in all inoculated animals permitted for
the first time, the employment of a spontan-
eous metastasizing animal tumour as a test
system for studying the behaviour of drugs
in the process of metastatic dissemination.
Hellmann also described the alterations
that drugs can bring about in the tumour
vasculature. Some drugs can normalize
the development of this vasculature so that
instead of ill-formed tortuous, vascular sinu-
soids lined by malignant cells, well formed,
well endothelialized blood vessels are pro-
duced, with the result that tumour cells
cannot escape into the circulation and
metastases are thereby prevented. These
changes may be brought about by drug doses
which still permit the primary implant to
grow at the same rate as control primary
tumours.
Hellmann also discussed the significance
of the circulating Lewis lung cell and the
methods of showing whether a compound
with anti-tumour activity also had anti-
metastatic activity.
The last speaker was G. Easty, whoB.A.C.R. WORKSHOP
discussed some important biochemical factors
which are now ofinterest during the develop-
ment of metastases, particularly in cancer of
the breast. He discussed the release of
substances from tumours which bring about
lysis of bone with consequent release of cal-
cium. He described methods of analysing
these factors in organ culture systems.
The model system consistedoflabelling the
bones of mice with radioactive calcium
chloride, dissecting out the calvaria and
dividing them into two. One half served as
control and the other as test. The bones
were cultured on grids and the tumour cells
placed at a distance from the bones so that
any factors released from the tumour would
diffuse through the medium and the resulting
release of Ca++ from the bone could be
measured. Prostaglandin E was a likely
candidate astheosteolyticsubstanceproduced
in breast carcinoma.
The demonstrations were given by the
same four speakers and consisted of practical
illustrations ofthe papers briefly summarized
here.
This meeting was supported by the Cancer
Research Campaign.
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